Zealand Pharma stock suffered its two worst days on record. Here’s what’s next for the weight loss drugmaker
While the market's enthusiasm for one of Zealand's experimental drugs has cooled, investors are shifting focus to amylin-based medicines as a growth driver
The Source
CNBC
US
Iran reportedly closes Strait of Hormuz again, casting shadow over nuclear talks
CNBC·15h ago·3 min read
Business
SNAP restrictions could change what shoppers buy — and food giants are watching
CNBC·20h ago·3 min read
US
Memory crisis hits such extremes that ‘even Apple can’t be safe’
CNBC·1d ago·3 min read
Business
Struggling to find a job? Try looking in Nevada
CNBC·1d ago·3 min read
Related
On this beat
Health
We’ve come a long way in combating Alzheimer’s disease over the past decade. The next decade will show even more stunning advances.
TWSJ·19h ago·3 min read
Health
Doctor goes above and beyond for her cancer patient, ending with a big surprise
CBS NEWS·1d ago·3 min read
Health
In-Person vs Online Couples Therapy: Which Option Suits Your Relationship Best?
AOHL·1d ago·3 min read
Health
Science‑Backed Approaches To Maintain Youthful Skin
AOHL·1d ago·3 min read